My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    Mol Cytogenet. 2009 Dec 9;2:26.

    Detailed molecular and clinical investigation of a child with a partial deletion of chromosome 11 (Jacobsen syndrome).

    Manolakos E, Orru S, Neroutsou R, Kefalas K, Louizou E, Papoulidis I, Thomaidis L, Peitsidis P, Sotiriou S, Kitsos G, Tsoplou P, Petersen MB, Metaxotou A.

    Bioiatriki S,A,, Laboratory of Genetics, Athens, Greece. emanolakos@bioiatriki.gr.

    Abstract

    ABSTRACT: BACKGROUND: Jacobsen syndrome (JBS) is a rare chromosomal disorder leading to multiple physical and mental impairment. This syndrome is caused by a partial deletion of chromosome 11, especially subband 11q24.1 has been proven to be involved. Clinical cases may easily escape diagnosis, however pancytopenia or thrombocytopenia may be indicative for JBS. RESULTS: We report a 7.5 years old boy presenting with speech development delay, hearing impairment and abnormal platelet function. High resolution SNP oligonucleotide microarray analysis revealed a terminal deletion of 11.4 Mb in size, in the area 11q24.1-11qter. This specific deletion encompasses around 170 genes. Other molecular techniques such as fluorescence in situ hybridization and multiplex ligation-dependent probe amplification were used to confirm the array-result. DISCUSSION: Our results suggest that the identification and detailed analysis of similar patients with abnormal platelet function and otherwise mild clinical features will contribute to identification of more patients with 11q deletion and JBS.

    PMID: 20003197 [PubMed - in process]PMCID: PMC2799424Free PMC Article

    Supplemental Content

    Click here to read Click here to read

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    Write to the Help Desk